Despite the development of SARS-CoV-2 vaccines, effective therapeutics are needed until worldwide immunity has been achieved. A study published in PLOS Pathogens by Adam Pickard and Karl Kadler
One of the most challenging aspects of cancer treatment is the huge variety of different tumors that can occur with each one potentially requiring a different solution because
The American College of Rheumatology today applauded the Centers for Medicare and Medicaid Services' decision to withdraw a proposed rule to implement the "Most Favored Nation" (MFN) payment
When you can’t escape from distressing intrusive thoughts, you’ll do things that make little sense to those outside your head. You might check that the front door is
Authorities scramble to provide drugs to treat a fungal disease affecting India's COVID-19 patients. A fungal disease called mucormycosis is emerging among hundreds of COVID-19 patients in India,
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection induces various health complications all over the body. New research published in the journal Nature found the presence of SARS-CoV-2
Researchers in the United States have identified several clinically approved compounds that could be repurposed for the treatment and prevention of coronavirus disease 2019 (COVID-19). By screening a
The onset of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, which causes coronavirus disease 2019 (COVID-19), has led to severe disruption to social and economic life,
The onset of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, which causes coronavirus disease 2019 (COVID-19), has led to severe disruption to social and economic life,
Nearly every older adult was prescribed a prescription drug that increased their risk of falling in 2017, according to new University at Buffalo research. The study found that
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok
